Home · Sports · Oct 19 archive
Hurts to Miss Season Due to Blood Clots
Confirmed
In Short: Sources indicate that Jalen Hurts, the Philadelphia Eagles quarterback, will miss the remainder of the season due to blood clots found in his lungs.
Sources indicate that Jalen Hurts, the Philadelphia Eagles quarterback, will miss the remainder of the season due to blood clots found in his lungs.
According to ESPN, Hurts played in the Eagles' 19-17 loss to the Jacksonville Jaguars despite the initial diagnosis, attempting 40 passes.
Tanner McKee took over as the starting quarterback in the Eagles' subsequent game against the Carolina Panthers, completing 26 of 45 passes for 215 yards and a touchdown in a 25-14 loss.
The Eagles waited to make the roster move until after consulting with medical experts, ruling Hurts out for Sunday's game against the Panthers.
Hurts' agent, Nicole Lynn, and the Eagles released a statement Monday, detailing his condition. The statement confirmed that Hurts has deep vein thrombosis and bilateral pulmonary emboli, meaning a blood clot traveled from his legs to his lungs.
The Eagles' medical team stated that Hurts is 'clinically stable and has no significant functional limitations,' but he will not be allowed to participate in football activities while on anticoagulation medication.
Sources informed of the diagnosis told Ian Rapoport and Adam Schefter that Hurts will undergo treatment involving blood thinners, expected to sideline him for at least three months.
The blood clot is considered 'provoked' because Hurts was cleated in his calf, sources told Rapoport, indicating a favorable prognosis with treatment and care.
Hurts did not sleep the night before the game against the Panthers because he was told that sleeping posed health risks associated with the clot.
The quarterback was in the hospital in London until 4 a.m. on the morning of the game against the Jaguars.
Jalen Hurts' prognosis is very good, and the Eagles expect a full recovery, according to the statement released by Lynn and the Eagles.
What this adds
The Eagles waited to make the roster move until after consulting with medical experts, ruling Hurts out for Sunday's game against the Panthers.
What's confirmed
- Sources indicate that Jalen Hurts, the Philadelphia Eagles quarterback, will miss the remainder of the season due to blood clots found in his lungs.
- According to ESPN, Hurts played in the Eagles' 19-17 loss to the Jacksonville Jaguars despite the initial diagnosis, attempting 40 passes.
- Tanner McKee took over as the starting quarterback in the Eagles' subsequent game against the Carolina Panthers, completing 26 of 45 passes for 215 yards and a touchdown in a 25-14 loss.
- The Eagles waited to make the roster move until after consulting with medical experts, ruling Hurts out for Sunday's game against the Panthers.
- Hurts' agent, Nicole Lynn, and the Eagles released a statement Monday, detailing his condition. The statement confirmed that Hurts has deep vein thrombosis and bilateral pulmonary emboli, meaning a blood clot traveled from his legs to his lungs.
- The Eagles' medical team stated that Hurts is 'clinically stable and has no significant functional limitations,' but he will not be allowed to participate in football activities while on anticoagulation medication.
- Sources informed of the diagnosis told Ian Rapoport and Adam Schefter that Hurts will undergo treatment involving blood thinners, expected to sideline him for at least three months.
- The blood clot is considered 'provoked' because Hurts was cleated in his calf, sources told Rapoport, indicating a favorable prognosis with treatment and care.
- Hurts did not sleep the night before the game against the Panthers because he was told that sleeping posed health risks associated with the clot.
- The quarterback was in the hospital in London until 4 a.m. on the morning of the game against the Jaguars.
- Jalen Hurts' prognosis is very good, and the Eagles expect a full recovery, according to the statement released by Lynn and the Eagles.
What's still developing
- "We anticipate that he will have the opportunity to resume contact football activities when off the blood thinners. In the meantime, he will remain active around the team and continue to condition. More importantly, we anticipate that he will have no long-term effects."